通过siaD核苷酸序列分析鉴定脑膜炎奈瑟菌Y群和W135群
Identification of Neisseria meningitidis serogroups Y and W135 by siaD nucleotide sequence analysis.
作者信息
Lewis C, Clarke S C
机构信息
Scottish Centre for Infection and Environmental Health, Clifton House, Clifton Place, Glasgow G3 7LN, Scotland.
出版信息
J Clin Microbiol. 2003 Jun;41(6):2697-9. doi: 10.1128/JCM.41.6.2697-2699.2003.
Abstract
Rapid serogrouping of meningococci is essential for the effective public health management of cases of the disease and the contacts of infected patients. Here we describe an accurate nucleotide-sequencing method for the confirmation of serogroup Y and W135 meningococci by siaD gene analysis from cultures of Neisseria meningitidis.
摘要
脑膜炎球菌的快速血清群分型对于该疾病病例及感染患者接触者的有效公共卫生管理至关重要。在此，我们描述了一种通过对脑膜炎奈瑟菌培养物进行siaD基因分析来确认Y群和W135群脑膜炎球菌的准确核苷酸测序方法。
相似文献
1
Identification of Neisseria meningitidis serogroups Y and W135 by siaD nucleotide sequence analysis.通过siaD核苷酸序列分析鉴定脑膜炎奈瑟菌Y群和W135群
J Clin Microbiol. 2003 Jun;41(6):2697-9. doi: 10.1128/JCM.41.6.2697-2699.2003.
2
Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease.连续使用两种基于多重聚合酶链反应的检测方法，用于同时鉴定和确定与侵袭性疾病相关的9种常见脑膜炎奈瑟菌血清群的荚膜状态。
J Clin Microbiol. 2006 Mar;44(3):1127-31. doi: 10.1128/JCM.44.3.1127-1131.2006.
3
Invasive meningococcal disease caused by Neisseria meningitidis strains expressing both serogroup Y and W-135 antigenic specificities.由同时表达Y群和W-135血清群抗原特异性的脑膜炎奈瑟菌菌株引起的侵袭性脑膜炎球菌病。
J Clin Microbiol. 2011 Jan;49(1):472-3. doi: 10.1128/JCM.01995-10. Epub 2010 Nov 10.
4
Nucleotide sequence analysis of the sialyltransferase genes of meningococcal serogroups B, C, Y and W135.B、C、Y和W135群脑膜炎球菌唾液酸转移酶基因的核苷酸序列分析
J Mol Microbiol Biotechnol. 2003;5(2):82-6. doi: 10.1159/000069978.
5
5' exonuclease assay for detection of serogroup Y Neisseria meningitidis.用于检测Y群脑膜炎奈瑟菌的5'核酸外切酶分析
J Clin Microbiol. 2002 Nov;40(11):4325-8. doi: 10.1128/JCM.40.11.4325-4328.2002.
6
High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.巴西南部脑膜炎奈瑟菌高毒力谱系的高流行率及W135:P1.5,2:ST-11克隆株的出现。
J Infect. 2008 Oct;57(4):324-31. doi: 10.1016/j.jinf.2008.07.014. Epub 2008 Sep 23.
7
Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.抗B、C、Y和W135群脑膜炎奈瑟菌的鼠杂交瘤单克隆抗体的血清学特异性及其作为血清分组试剂通过间接全细胞酶联免疫吸附测定法的效用评估。
Clin Diagn Lab Immunol. 2005 Jan;12(1):152-6. doi: 10.1128/CDLI.12.1.152-156.2005.
8
Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.1990 至 2005 年巴西侵袭性 W 群 135 型脑膜炎奈瑟菌的表型和分子特征。
J Infect. 2010 Mar;60(3):209-17. doi: 10.1016/j.jinf.2009.11.014. Epub 2010 Jan 6.
9
Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.将A、C、W135和Y血清群脑膜炎奈瑟菌抗荚膜总免疫球蛋白G（IgG）、IgG1和IgG2浓度分配至参考血清。
Clin Diagn Lab Immunol. 2004 Jan;11(1):1-5. doi: 10.1128/cdli.11.1.1-5.2004.
10
New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.针对A、W135、C和Y血清群脑膜炎奈瑟菌的新型快速诊断检测方法。
PLoS Med. 2006 Sep;3(9):e337. doi: 10.1371/journal.pmed.0030337.
引用本文的文献
1
Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species.用于检测和分型脑膜炎相关细菌种类的诊断性DNA寡核苷酸微阵列的开发与评估
High Throughput. 2018 Oct 16;7(4):32. doi: 10.3390/ht7040032.
2
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.利用侵袭性和携带分离株集合对脑膜炎奈瑟菌进行荚膜分型的表型和基因型方法比较
J Clin Microbiol. 2016 Jan;54(1):25-34. doi: 10.1128/JCM.01447-15. Epub 2015 Aug 26.
3
Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.从14至22岁意大利学生中分离出的脑膜炎奈瑟菌携带菌株的分子和血清学多样性。
J Clin Microbiol. 2014 Jun;52(6):1901-10. doi: 10.1128/JCM.03584-13. Epub 2014 Mar 19.
4
Molecular discrimination between Neisseria meningitidis serogroups W-135 and Y based on the nucleotide recognition domain sequence of the capsule polymerases.基于荚膜聚合酶核苷酸识别域序列对脑膜炎奈瑟菌W-135和Y血清群进行分子鉴别。
J Clin Microbiol. 2010 Sep;48(9):3459-60. doi: 10.1128/JCM.00859-10. Epub 2010 Jul 14.
5
Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.抗B、C、Y和W135群脑膜炎奈瑟菌的鼠杂交瘤单克隆抗体的血清学特异性及其作为血清分组试剂通过间接全细胞酶联免疫吸附测定法的效用评估。
Clin Diagn Lab Immunol. 2005 Jan;12(1):152-6. doi: 10.1128/CDLI.12.1.152-156.2005.
6
PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z.基于聚合酶链反应的检测脑膜炎奈瑟菌29E、X和Z血清群的检测方法。
J Clin Microbiol. 2004 Apr;42(4):1764-5. doi: 10.1128/JCM.42.4.1764-1765.2004.
7
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.运用实时聚合酶链反应解决脑膜炎奈瑟菌血清群鉴定中玻片凝集试验的差异。
J Clin Microbiol. 2004 Jan;42(1):320-8. doi: 10.1128/JCM.42.1.320-328.2004.
本文引用的文献
1
2
Laboratory confirmation of meningococcal disease in Scotland, 1993-9.1993 - 1999年苏格兰脑膜炎球菌病的实验室确诊情况
J Clin Pathol. 2002 Jan;55(1):32-6. doi: 10.1136/jcp.55.1.32.
3
Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis.用于脑膜炎奈瑟菌临床分离株特征鉴定的多位点序列分型半自动化方法
J Clin Microbiol. 2001 Sep;39(9):3066-71. doi: 10.1128/JCM.39.9.3066-3071.2001.
4
Interruption of siaD in a meningococcal carrier isolate mediated by an insertion sequence.由插入序列介导的脑膜炎球菌携带者分离株中siaD的中断。
Clin Diagn Lab Immunol. 2001 Mar;8(2):465-6. doi: 10.1128/CDLI.8.2.465-466.2001.
5
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.英国使用脑膜炎球菌C群结合疫苗的血清学依据：对保护相关性的重新评估。
Infect Immun. 2001 Mar;69(3):1568-73. doi: 10.1128/IAI.69.3.1568-1573.2001.
6
Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine.引入C群脑膜炎球菌疫苗后对脑膜炎球菌病血清群发病率的影响。
Scott Med J. 2000 Jun;45(3):67. doi: 10.1177/003693300004500301.
7
Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.与ET-37复合群相关的脑膜炎奈瑟菌W135血清型分离株。
Emerg Infect Dis. 2000 Jul-Aug;6(4):428-9. doi: 10.3201/eid0604.000423.
8
The changing epidemiology of meningococcal disease in the United States, 1992-1996.1992 - 1996年美国脑膜炎球菌病流行病学的变化
J Infect Dis. 1999 Dec;180(6):1894-901. doi: 10.1086/315158.
9
Meningococcal conjugate vaccines: new opportunities and new challenges.脑膜炎球菌结合疫苗：新机遇与新挑战。
Lancet. 1999 Aug 21;354(9179):615-6. doi: 10.1016/s0140-6736(99)00252-4.
10
The epidemiology and control of invasive meningococcal disease.侵袭性脑膜炎球菌病的流行病学与防控
Pediatr Infect Dis J. 1999 Jul;18(7):633-4. doi: 10.1097/00006454-199907000-00014.
Zotero 插件